Insiders Legend Biotech Corporation

Equities

LEGN

US52490G1022

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-12 pm EDT			5-day change	1st Jan Change
45.75 ^USD	+3.39%		+4.84%	-23.97%

Jun. 03	Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses	MT
Jun. 03	Legend Biotech Corporation Shares Data on the Earlier Use to Date of CARVYKTI in the Treatment of Multiple Myeloma and Important Subgroup Analyses At ASCO and EHA	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Legend Biotech Corporation Announces Management Changes	Mar. 11	CI
Legend Biotech Corporation Announces Appointment of Mythili Koneru, M.D., Ph.D. as Chief Medical Officer	23-04-11	CI
Legend Biotech Establishes Strategic Advisory Board	23-04-03	CI
Legend Biotech Corporation Elects Philip Yau as Director	22-10-17	CI
Legend Biotech Corporation Announces Board Changes	22-08-04	CI
Genscript Biotech's Nasdaq-listed Unit Promotes Finance VP to CFO; Shares Slip 5%	22-05-10	MT
Legend Biotech Names New CFO	22-05-09	MT
Legend Biotech Appoints Lori Macomber as Chief Financial Officer	22-05-09	CI
Legend Biotech Announces Executive Changes	22-04-03	CI
Legend Biotech Corporation Announces Appointment of Guowei Fang as Global Head of Research and Early Development	22-04-01	CI
Legend Biotech Announces Appointment of Ying Huang to the Board of Directors	21-12-30	CI
Legend Biotech Announces Appointment of Patrick Casey to the Board of Directors	20-12-03	CI
Legend Biotech Corporation Announces Board Changes	20-11-23	CI
Legend Biotech : Names Ye Wang as Chair, Ying Huang as Chief Executive Officer	20-11-09	MT
Legend Biotech Corporation Appoints Ying Huang as Chief Executive Officer	20-11-09	CI
Legend Biotech Corporation Announces Appointment of Ye Wang as Chairwoman of the Board	20-11-09	CI
Legend Biotech Corporation Appoints Ying Huang as Interim Chief Executive Officer	20-09-21	CI
Genscript Biotech : Legend names founder Frank Zhang as chief executive officer	20-08-02	RE
Legend Biotech Corporation Announces Management Changes	20-08-02	CI
Legend Biotech Corporation Announces Resignation of Yuan Xu Has from its Board of Directors	20-08-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Legend Biotech Corporation

Equities

LEGN

US52490G1022

Insiders

Filters